Results 211 to 220 of about 181,230 (381)

Prescribing Inflammatory Bowel Disease Medications in Chronic Kidney Disease: A Practical Guide

Alimentary Pharmacology &Therapeutics, EarlyView.
Most therapies used in inflammatory bowel disease appear safe and effective when used in chronic kidney disease including on renal replacement therapy, particularly biologic therapies. Some caution should be considered when using conventional therapies and JAK inhibitors.
Lynna Chen, Ashish Srinivasan, Suet‐Wan Choy, Jeffrey Van, Habeeb Habeeb, Andrew Nguyen, Abhinav Vasudevan   +6 more
wiley   +1 more source

Folic acid deficiency declined substantially after introduction of the mandatory fortification programme in Queensland, Australia: a secondary health data analysis. [PDF]

Public Health Nutr, 2019
Slagman A, Harriss L, Campbell S, Muller R, McDermott R.   +4 more
europepmc   +1 more source

The Impact of Folic Acid/VB12 Deficiency on Essential Hypertension in Children and Adolescents: from a Nested Case-control and a Cohort Study [PDF]

, 2023
Xiaohua Liang, Yun He, Guomin Hu, Jishuang Tong, Yanling Ren, Lan S. Chen, Yuwei Wang, Xizhou An, Xiaoping Jiang, Muhammad Fahad Tahir, Yang Bi, Qin Liu   +11 more
openalex   +1 more source

Significantly higher frequencies of hematinic deficiencies and hyperhomocysteinemia in oral precancer patients

Journal of the Formosan Medical Association, 2019
Background/Purpose: Our previous studies found relatively higher frequencies of anemia, hematinic deficiencies, and hyperhomocysteinemia in patients with different types of oral mucosal diseases.
Yu-Hsueh Wu, Yang-Che Wu, Fang-Yeh Chu, Shih-Jung Cheng, Andy Sun, Hsin-Ming Chen   +5 more
doaj  

Folic acid as ultimate in disease prevention:Beware of vitamin B12 deficiency [PDF]

, 2004
Stephen Malnick, Sorel Goland
openalex   +1 more source

ZIP10 as a potential therapeutic target in acute myeloid leukaemia

British Journal of Haematology, EarlyView.
Increased intracellular zinc levels in acute myeloid leukaemia blasts with upregulated expression of zinc influx transporters ZIP6 and ZIP10. Targeting ZIP10 with a surface antibody represents a potential therapeutic strategy. Created in BioRender. Rolles, B. (2025) https://BioRender.com/bwrtof1.
Benjamin Rolles, Nicolas Chatain, Richard Görg, Margherita Vieri, Nora Tillmann‐Tröster, Marcel G. Bourgeois, Deborah Christen, Jeanette Walter, Addison C. Hillerbrand, Kyle A. Romine, Kathryn M. Taylor, Jens Bertram, Edgar Jost, Steffen Koschmieder, Fabian Beier, Maximilian Stahl, Tim H. Brümmendorf, Lothar Rink, Inga Wessels   +18 more
wiley   +1 more source

Coloured polyhydroxyalkanoates: A review

Coloration Technology, EarlyView.
Abstract Polyhydroxyalkanoates (PHAs) are a class of biopolymers produced by various microorganisms, with poly(3‐hydroxybutyrate) being the most extensively studied. PHAs are widely studied as substitutes for conventional plastics due to their similar physicochemical properties. However, the production cost of PHAs remains high.
Maria Luiza de Oliveira Zanini, Camila Rios Piecha, Ketnen Rieffel das Chagas, Patrícia Silva Diaz   +3 more
wiley   +1 more source

A Rare Case of Severe Haemolytic Anaemia Due to Folic Acid Deficiency in a Patient with Beta Thalassaemia Trait. [PDF]

Cureus
Subair A, Rajkanna J.
europepmc   +1 more source

Pregnancy outcomes in women with young‐onset type 2 diabetes: the impact of age of diabetes diagnosis and duration of diabetes

Diabetic Medicine, EarlyView.
Abstract Aims Young‐onset type 2 diabetes mellitus (YT2DM) is an aggressive phenotype, with some claiming that diagnosis at <40 years of age represents a distinct higher risk group. Others have suggested restricting YT2DM to those diagnosed at <30 years of age.
Xi May Zhen, Glynis Ross, Amanda Gauld, Alberto Nettel‐Aguirre, Stephanie Noonan, Maria Constantino, Arianne Sweeting, Anna‐Jane Harding, Adam Mackie, Hend Chatila, Margaret McGill, Timothy Middleton, Ted Wu, Stephen Twigg, Jencia Wong   +14 more
wiley   +1 more source

In vitro models of valproic acid to assess neurodevelopmental toxicity: A scoping review

Epilepsia, EarlyView.
Abstract Valproic acid (VPA) is a first‐line antiseizure medication (ASM) that is highly efficacious for treating generalized and focal epilepsy disorders. Unfortunately, due to its strong association with teratogenic effects culminating in fetal valproate spectrum disorder (FVSD), which may include neurocognitive and neurobehavioral deficits, the drug
Daniel Sandvik, Elena Vianca, Alison Anderson, Muhammad Shahid Javaid, Terence J. O'Brien, Ana Antonic‐Baker   +5 more
wiley   +1 more source